[{"id":"9ab66824-8e3a-4720-b4ba-ed7f93a0f589","acronym":"PMB-BAFFR-102","url":"https://clinicaltrials.gov/study/NCT05370430","created_at":"2023-09-13T18:45:10.718Z","updated_at":"2024-07-02T16:35:37.370Z","phase":"Phase 1","brief_title":"BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL","source_id_and_acronym":"NCT05370430 - PMB-BAFFR-102","lead_sponsor":"PeproMene Bio, Inc.","biomarkers":" BCL2 • BCL6","pipe":" | ","alterations":" BCL6 rearrangement • BCL2 rearrangement • CD20 negative • TNFRSF13C expression","tags":["BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BCL6 rearrangement • BCL2 rearrangement • CD20 negative • TNFRSF13C expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PMB-CT01"],"overall_status":"Recruiting","enrollment":" Enrollment 36","initiation":"Initiation: 06/13/2022","start_date":" 06/13/2022","primary_txt":" Primary completion: 07/13/2027","primary_completion_date":" 07/13/2027","study_txt":" Completion: 06/13/2028","study_completion_date":" 06/13/2028","last_update_posted":"2023-09-12"}]